 
                        
                                                
                     
            20+ years in 
CRO business
                            12 international
offices
                            5000+ investigational sites
and KOL database
                            90+ audits passed
400+ completed
trials worldwide
                            100+ full-time
employees
                             
    
                        We offer a tailored approach to each project and client with end-to-end support for Phase I-V studies following the latest ICH-GCP, EMA, and FDA guidelines and local regulations.                                    Learn more
                    
                Learn more
            Our clients
 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                 
                Let’s keep in touch!
Get the latest news about GCT and the projects we support in a monthly email. View the mailing archive
 
                   
         
                         
                         
                         
                         
                         
                         
                         
                         
                 
                 
                 
                 
                 
                 
                         
                        